Get started
Author

Jenniffer Linares

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy
2023 · Jenniffer Linares, Anna Sallent-Aragay, et al. · Nature Communications · 117
PDF
Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
2023 · Núria Mulet-Margalef, Jenniffer Linares, et al. · Cancers · 117
PDF
Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy
2021 · Jenniffer Linares, Juan A. Marín-Jiménez, et al. · Frontiers in Cell and Developmental Biology · 115
PDF
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
2022 · Elisa I. Rivas, Jenniffer Linares, et al. · Nature Communications · 74
PDF
Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer
2018 · Maite Antonio, Juana Saldaña, et al. · British Journal of Cancer · 49
PDF
Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road
2024 · Alejandro Ríos-Hoyo, Xavier Monzonís, et al. · Frontiers in Pharmacology · 44
PDF
Minimal Residual Disease, Metastasis and Immunity
2021 · Jordi Badia-Ramentol, Jenniffer Linares, et al. · Biomolecules · 42
PDF
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing
2025 · Alice Perucca, Andrea Gómez Llonín, et al. · Nature Communications · 41
PDF
The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice
2023 · Jordi Badia-Ramentol, Francisco Gimeno-Valiente, et al. · Cancer Treatment Reviews · 41
PDF
Peptide–Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells
2023 · Jenniffer Linares, Monica Varese, et al. · Journal of Medicinal Chemistry · 17
Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives
2025 · Valentino Martelli, Joana Vidal, et al. · Cancers · 11
PDF
Evaluation of femtosecond-LA-ICP-TOFMS for multi-elemental mapping at cellular resolution of human-tissue from cancer patients
2024 · Jorge Pisonero, Alexandre Calon, et al. · Optics & Laser Technology · 9
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study
2025 · V. Martelli, J. Vidal, et al. · ESMO Open · 8
Emergence of long-term surviving patients with the introduction of Cetuximab in recurrent/metastatic disease of squamous cell carcinoma of head and neck
2016 · Jenniffer Linares, Antonio Rullan, et al. · Oral Oncology · 8
Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases
2021 · C. Fabregat-Franco, A. Stradella, et al. · Clinical & Translational Oncology · 6
Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy
2026 · Mar Iglesias Coma, Jordi Badia-Ramentol, et al. · Gut · 4
Abstract PR009: Application of Liquid Biopsy-RECIST (LB-RECIST) criteria to track metastatic colorectal cancer (mCRC) molecular response in first-line (1L) setting: Findings from the PLATFORM-B study
2024 · Valentino Martelli, Joana Vidal, et al. · Clinical Cancer Research · 1
ctDNA MRD combined with CODEX2 to identify high-risk colorectal cancer with potential sensitivity to immunotherapy.
2026 · Francisco Gimeno-Valiente, Belén MartÃnez Castedo, et al. · Journal of Clinical Oncology
PDF
832P Aggregate variant allele frequency variations as a prognostic factor in first-line metastatic colorectal cancer patients: Results from PLATFORM-B trial
2025 · V. Martelli, J. Vidal, et al. · Annals of Oncology
PDF
769P Implementing liquid biopsy in stage II colon cancer: Economic impact across real-world scenarios
2025 · A. Pastorino, V. Martelli, et al. · Annals of Oncology
101P Cost-effectiveness of liquid biopsy in stage II colon cancer: A real-world analysis
2025 · V. Martelli, L. Mastracci, et al. · Annals of Oncology
PDF
CODEX2: A novel scoring system for CDX2 loss in colon cancer—Unraveling prognostic insights and therapeutic opportunities.
2025 · Francisco Gimeno-Valiente, Brenda Palomar de Lucas, et al. · Journal of Clinical Oncology
Plasma shallow whole-genome sequencing profiling in patients with RAS WT metastatic colorectal cancer (mCRC) undergoing first-line anti-EGFR therapy.
2025 · Valentino Martelli, Joana Vidal Barrull, et al. · Journal of Clinical Oncology
Abstract B038: Application of Liquid Biopsy-RECIST (LB-RECIST) criteria to track metastatic colorectal cancer (mCRC) molecular response in first-line (1L) setting: Findings from the PLATFORM-B study
2024 · Valentino Martelli, Joana Vidal, et al. · Clinical Cancer Research
360P Epigenetic engineering on CDX2 allows to determine the interplaying consequences with other genetic and transcriptomic events in colorectal cancer
2022 · F. Gimeno-Valiente, E. Duréndez, et al. · Annals of Oncology
Works count: 29
Citation count: 704
H-index: 11
I10-index: 11
Year
Topic
Type